bumetanide
(byoo met' a nide)
Bumex, Burinex (CAN)
Pregnancy Category C
Drug class
Loop (high ceiling) diuretic
Therapeutic actions
Inhibits the reabsorption of sodium and chloride from the proximal and distal renal tubules and the loop of Henle, leading to a natriuretic diuresis.
Indications
· Edema associated with CHF, cirrhosis, renal disease
· IV: Acute pulmonary edema
· Unlabeled use: Treatment of adult nocturia (not effective in men with BPH)
Contraindications and cautions
· Contraindicated with allergy to bumetanide; electrolyte depletion; anuria, severe renal failure; hepatic coma; lactation.
· Use cautiously with SLE, gout, diabetes mellitus, pregnancy.
Available forms
Tablets—0.5, 1, 2 mg; injection—0.25 mg/mL
Dosages
ADULTS
Oral
0.5–2 mg/day PO in a single dose; may repeat at 4- to 5-hr intervals up to a maximum daily dose of 10 mg. Intermittent dosage schedule of drug and rest days is 3–4 on/1–2 off, which is most effective with edema.
Parenteral
0.5–1 mg IV or IM. Give over 1–2 min. Dose may be repeated at intervals of 2–3 hr. Do not exceed 10 mg/day.
PEDIATRIC PATIENTS
Not recommended for children < 18 yr.
GERIATRIC PATIENTS OR PATIENTS WITH RENAL IMPAIRMENT
A continuous infusion of 12 mg over 12 hr may be more effective and less toxic than intermittent bolus therapy.
Pharmacokinetics
Route | Onset | Peak | Duration |
Oral | 30–60 min | 1–2 hr | 4–6 hr |
IV | Minutes | 15–30 min | 30–60 min |
Metabolism: T1/2: 60–90 min
Distribution: Crosses placenta; may enter breast milk
Excretion: Urine
IV facts
Preparation: May be given direct IV or diluted in solution with 5% dextrose in water, 0.9% sodium chloride, or lactated Ringer's solution. Discard unused solution after 24 hr.
Infusion: Give by direct injection slowly, over 1–2 min. Further diluted in solution; give slowly; do not exceed 10 mg/day.
Adverse effects
· CNS: Asterixis, dizziness, vertigo, paresthesias, confusion, fatigue, nystagmus, weakness, headache, drowsiness, fatigue, blurred vision, tinnitus, irreversible hearing loss
· CV: Orthostatic hypotension, volume depletion, cardiac arrhythmias, thrombophlebitis
· GI: Nausea, anorexia, vomiting, diarrhea, gastric irritation and pain, dry mouth, acute pancreatitis, jaundice
· GU: Polyuria, nocturia, glycosuria, renal failure
· Hematologic: Hypokalemia, leukopenia, anemia, thrombocytopenia
· Local: Pain, phlebitis at injection site
· Other: Muscle cramps and muscle spasms, weakness, arthritic pain, fatigue, hives, photosensitivity, rash, pruritus, sweating, nipple tenderness
Interactions
Drug-drug
· Decreased diuresis and natriuresis with NSAIDs
· Increased risk of cardiac glycoside toxicity (secondary to hypokalemia)
· Increased risk of ototoxicity if taken with aminoglycoside antibiotics, cisplatin
Nursing considerations
Assessment
· History: Allergy to bumetanide, electrolyte depletion, anuria, severe renal failure, hepatic coma, SLE, gout, diabetes mellitus, lactation
· Physical: Skin color, lesions; edema; orientation, reflexes, hearing; pulses, baseline ECG, BP, orthostatic BP, perfusion; R, pattern, adventitious sounds; liver evaluation, bowel sounds; urinary output patterns; CBC, serum electrolytes (including calcium), blood sugar, LFTs, renal function tests, uric acid, urinalysis
Interventions
· Give with food or milk to prevent GI upset.
· Mark calendars or use reminders if intermittent therapy is best for treating edema.
· Give single dose early in day so increased urination will not disturb sleep.
· Avoid IV use if oral use is possible.
· Arrange to monitor serum electrolytes, hydration, liver function during long-term therapy.
· Provide diet rich in potassium or supplemental potassium.
Teaching points
· Record alternate day or intermittent therapy on a calendar or dated envelopes.
· Take the drug early in day so increased urination will not disturb sleep; take with food or meals to prevent GI upset.
· Weigh yourself on a regular basis, at the same time, and in the same clothing; record the weight on your calendar.
· You may experience these side effects: Increased volume and frequency of urination; dizziness, feeling faint on arising, drowsiness (avoid rapid position changes; hazardous activities, such as driving; and alcohol consumption); sensitivity to sunlight (use sunglasses, sunscreen, wear protective clothing); increased thirst (suck sugarless lozenges; use frequent mouth care); loss of body potassium (a potassium-rich diet, or supplement will be needed).
· Report weight change of more than 3 pounds in 1 day; swelling in ankles or fingers; unusual bleeding or bruising; nausea, dizziness, trembling, numbness, fatigue; muscle weakness or cramps.
Adverse effects in Italic are most common; those in Bold are life-threatening.
0 comments:
Post a Comment